Yosuke Hirasawa, Takahiro Adachi, Takeshi Hashimoto, Wataru Fukuokaya, Yuhei Koike, Yuji Yata, Kazumasa Komura, Taizo Uchimoto, Takuya Tsujino, Kazuki Nishimura, et al. Comparison of the efficacy of enfortumab vedotin between patients with metastatic urothelial carcinoma who were treated with avelumab or pembrolizumab: real-world data from a multi-institutional study in Japan. Journal of cancer research and clinical oncology. 2024. 150. 4. 182-182
Ko Nakamura, Takaya Ohno, Teruo Inamoto, Tomoaki Takai, Taizo Uchimoto, Tatsuo Fukushima, Kazuki Nishimura, Yusuke Yano, Kyosuke Nishio, Shoko Kinoshita, et al. Pattern of expression of microRNA in patients with radiation induced bladder injury. Oncology. 2023
Wataru Fukuokaya, Yuhei Koike, Yuji Yata, Kazumasa Komura, Taizo Uchimoto, Takuya Tsujino, Masanobu Saruta, Kiyoshi Takahara, Kazutoshi Fujita, Takafumi Minami, et al. Real world evidence of enfortumab vedotin in patients with advanced urothelial cancer: A multicenter observational study. International journal of urology : official journal of the Japanese Urological Association. 2023
Kazumasa Komura, Kensuke Hirosuna, Satoshi Tokushige, Takuya Tsujino, Kazuki Nishimura, Mitsuaki Ishida, Takuo Hayashi, Ayako Ura, Takaya Ohno, Shogo Yamazaki, et al. The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder Cancer. Molecular Cancer. 2023. 22. 1
Takuya Tsujino, Kazumasa Komura, Teruo Inamoto, Ryoichi Maenosono, Takeshi Hashimoto, Takahiro Adachi, Yosuke Hirasawa, Satoshi Tokushige, Takaya Ohno, Shogo Yamazaki, et al. Nephron-sparing ureteroscopic surgery vs. radical nephroureterectomy: comparable survival-outcomes in upper tract urothelial carcinoma. World journal of urology. 2023